Birzeit Pharmaceuticals Company

PLSE:BPC Stock Report

Market Cap: US$145.0m

Birzeit Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BPC?
Owner TypeNumber of SharesOwnership Percentage
Sovereign Wealth Funds2,554,7036.59%
Private Companies3,289,7018.49%
Individual Insiders9,016,69823.3%
General Public23,903,79661.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 4 shareholders own 38.34% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.8%
Talal Kadhim Nasereddin
6,505,346US$24.3m0%no data
8.49%
Razan Center For Infertility
3,289,701US$12.3m0%no data
6.59%
Aswak Investment Porfolios Company
2,554,703US$9.6m0%no data
6.48%
Firas Kathem Nasereddin
2,511,352US$9.4m0%no data